School of Journalism and Communication, Hua Qiao University, Xiamen, 361021, China.
Business Analytics Research Center, Chang Gung University, Taoyuan, 33302, Taiwan.
BMC Psychol. 2022 May 29;10(1):138. doi: 10.1186/s40359-022-00846-0.
This study investigated the effects of the loving-kindness meditation (LKM) on employees' mindfulness, affect, altruism and knowledge hiding.
In total, 100 employees were recruited from a knowledge-based enterprise in China and randomly divided into the LKM training group (n = 50) and the control group (n = 50). The LKM training group underwent LKM training for 8 weeks, while the control group did not. Seven main variables (mindfulness, altruism positive affect, negative affect, playing dumb, rationalized hiding, and evasive hiding) were measured both before (pre-test) and after (post-test) the LKM training intervention.
The LKM intervention significantly increased participants' altruism, and significantly reduced negative affect, playing dumb and evasive hiding, but did not significantly improve mindfulness, positive affect, and rationalized hiding.
LKM significantly improved employees' altruism, and significantly reduce their negative affect, but did not significantly improve their mindfulness and positive affect. For knowledge hiding, LKM significantly reduced playing dumb and evasive hiding, but had no significant effect on rationalized hiding. These results further elucidate the psychological effects of LKM and suggest the possibility of reducing knowledge hiding in the workplace.
ChiCTR2200057460. Registered in Chinese Clinical Trial Registry (ChiCTR), 13 March 2022-Retrospectively registered.
本研究旨在探讨仁爱冥想(LKM)对员工正念、情感、利他主义和知识隐藏的影响。
共招募 100 名来自中国一家知识型企业的员工,随机分为 LKM 训练组(n=50)和对照组(n=50)。LKM 训练组接受 8 周的 LKM 训练,而对照组不接受。在 LKM 训练干预前后(前测和后测)测量了正念、利他主义、积极情感、消极情感、装傻、合理化隐藏和逃避隐藏等 7 个主要变量。
LKM 干预显著提高了参与者的利他主义,显著降低了消极情感、装傻和逃避隐藏,但对正念、积极情感和合理化隐藏没有显著改善。
LKM 显著改善了员工的利他主义,显著降低了他们的消极情绪,但对他们的正念和积极情绪没有显著影响。对于知识隐藏,LKM 显著减少了装傻和逃避隐藏,但对合理化隐藏没有显著影响。这些结果进一步阐明了 LKM 的心理效应,并提示了在工作场所减少知识隐藏的可能性。
ChiCTR2200057460. 在中国临床试验注册中心(ChiCTR)注册,于 2022 年 3 月 13 日进行了回顾性注册。